Digital monitoring by whole body photography and sequential digital dermoscopy detects thinner melanomas.

INTRODUCTION Population screening for melanoma remains controversial. There are no studies demonstrating that population screening increases survival. As prognosis of melanoma is directly related to Breslow thickness, a surrogate marker of survival is thickness of melanoma. The development of several self-referred, whole-body photography and sequential digital dermoscopy imaging services reflects the public's concern regarding melanoma. AIM To assess the ability of one of these services to detect melanoma at an early, thin stage. METHODS Demographic and histological details from 100 melanomas diagnosed through self-referred whole-body photography and sequential digital dermoscopy imaging service compared to those diagnosed through traditional methods from data held by the New Zealand Cancer Registry. RESULTS There were 52 invasive and 48 in-situ melanomas: 90% superficial spreading type, 6% lentigo-maligna type and 4% nodular on histology. Forty-eight were diagnosed on first visit; the remainder by serial digital dermoscopy. Thirty-five percent of patients reported having had previous primary melanoma. In 60%, patients had been concerned by the lesion, the rest (40%) detected solely by screening. Patients diagnosed by whole-body photography and sequential digital dermoscopy screening had thinner melanomas compared to the Registry data: 69% <0.75 mm Breslow thickness compared to 52% (p=0.0216); only 1.9% thicker than 3 mm compared to 10.8% (p=0.067). DISCUSSION Melanomas detected by self-referred, whole-body photography with sequential digital dermoscopy service are thinner than melanomas detected by traditional diagnostic methods. It remains to be determined whether earlier diagnosis results in improved survival.

[1]  P. Box Clinical outcomes from skin screening clinics within a community-based melanoma screening program , 2006 .

[2]  S. Swetter,et al.  Factors related to the presentation of thin and thick nodular melanoma from a population‐based cancer registry in Queensland Australia , 2009, Cancer.

[3]  M. Mazumdar,et al.  Changes in the presentation of nodular and superficial spreading melanomas over 35 years , 2008, Cancer.

[4]  L. Fritschi,et al.  Validity of melanoma diagnosis in a community-based screening program. , 2006, American journal of epidemiology.

[5]  E. Herrera‐Ceballos,et al.  Growth rate as a prognostic factor in localized invasive cutaneous melanoma , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  J. Aitken,et al.  Who attends skin cancer clinics within a randomized melanoma screening program? , 2006, Cancer detection and prevention.

[7]  L. Schouten,et al.  Volunteer Melanoma Screenings: Follow‐Up, Compliance, and Outcome , 1997, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[8]  R. Delfino,et al.  Positive predictive value for presumptive diagnoses of skin cancer and compliance with follow-up among patients attending a community screening program. , 1998, Preventive medicine.

[9]  Donald R. Miller,et al.  Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness. , 2009, Archives of dermatology.

[10]  Josep Malvehy,et al.  Dermoscopy report: proposal for standardization. Results of a consensus meeting of the International Dermoscopy Society. , 2007, Journal of the American Academy of Dermatology.

[11]  M. Coory,et al.  Trends in melanoma mortality in Australia: 1950–2002 and their implications for melanoma control , 2005, Australian and New Zealand journal of public health.

[12]  M Rademaker,et al.  Successful triage of patients referred to a skin lesion clinic using teledermoscopy (IMAGE IT trial) , 2009, The British journal of dermatology.

[13]  A. Reeder,et al.  The incidence and thickness of cutaneous malignant melanoma in New Zealand 1994-2004. , 2008, The New Zealand medical journal.

[14]  Donald R. Miller,et al.  The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. , 2003, Journal of the American Academy of Dermatology.

[15]  U. P. S. T. Force,et al.  Screening for skin cancer: recommendations and rationale. , 2001, American family physician.

[16]  K. Smalley,et al.  Melanoma Biomarkers , 2012, Molecular Diagnosis & Therapy.

[17]  D. English,et al.  Presentation and detection of invasive melanoma in a high-risk population. , 2006, Journal of the American Academy of Dermatology.

[18]  L. Schouten,et al.  Skin cancer screening focusing on melanoma yields more selective attendance. , 1995, Archives of dermatology.

[19]  D. Rigel,et al.  Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program. , 1996, Journal of the American Academy of Dermatology.